ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,163, issued on Oct. 21, was assigned to Jazz Pharmaceuticals Therapeutics Inc. (Palo Alto, Calif.).
"Liposomal formulations of Bcl inhibitors" was invented by Paul Tardi (Surrey, Canada), Leon Wan (Vancouver, Canada), Shyam Madhusudan Garg (Richmond, Canada), Jun Gao (Coquitlam, Canada) and Philippe Legros (Burnaby, Canada).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are liposomes comprising B-cell lymphoma (Bcl) protein inhibitors, compositions comprising such liposomes, and methods using such formulations for treating hyperproliferative disorders."
The patent was filed on July 15, 2022, under Application No. 17/813,001.
*For fu...